By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Bracco Diagnostics Inc. 

107 College Road East

Princeton  New Jersey  08540  U.S.A.
Phone: 609-514-2200 Fax: 609-514-2424



Company News
The Centers for Medicare & Medicaid Services Approved Bracco Diagnostics Inc. Ultrasound Contrast Agent, Lumason (Sulfur Hexaflouride Lipid-Type A Microspheres) For Injectable Suspension, For Reimbursement, Under HOPPS 10/12/2015 8:35:45 AM
Bracco Diagnostics Inc. And Amerinet, Inc. Announce Group Purchasing Agreement To Include Lumasontm (Sulfur Hexafluoride Lipid-Type A Microspheres) For Injectable Suspension For Contrast Echocardiography 8/3/2015 10:56:39 AM
Bracco Diagnostics Inc. Creates First And Only U.S. FDA-Approved Multi-Dose Compliant Contrast Medium As Breakthrough Solution For Point-Of-Care Use In The CT Suite 11/24/2014 6:41:21 AM
Bracco Diagnostics Inc. Release: FDA Approves A New Ultrasound Imaging Agent 10/14/2014 7:59:27 AM
Nordion International Signs Two-Year Strontium-82 Supply Contract With Bracco Diagnostics Inc. 3/4/2014 10:04:30 AM
Emergent BioSolutions (EBS) Closes on Its Acquisition of Healthcare Protective Products Division From Bracco Diagnostics Inc. 8/2/2013 9:34:09 AM
Why Emergent BioSolutions (EBS) Paid $26 Million for Anti-Chem Lotion From Bracco Diagnostics Inc. 4/26/2013 7:47:49 AM
Bracco Diagnostics Inc. Recalls Isovue PFS Injector Syringes 11/28/2012 6:38:12 AM
FDA Approves Use of Bracco Diagnostics Inc.'s MultiHance Injection in MRA 7/30/2012 7:48:17 AM
Bracco Diagnostics Inc. Receives U.S. FDA Approval for Expanded Labeling of MultiHanceĀ® (gadobenate dimeglumine) Injection in Magnetic Resonance Angiography 7/27/2012 10:02:47 AM